Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Clinical Laboratory Analysis|September 25, 2021
Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?Moritz Mirna, Mario Holnthoner, Albert Topf, et al.Frontiers in Pharmacology|December 11, 2023
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathyVera Paar, Michael Haslinger, Philipp Krombholz-Reindl, et al.Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.Journal of the American College of Cardiology|September 30, 2017
Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart FailureShin Watanabe, Kiyotake Ishikawa, Kenneth Fish, et al.Frontiers in Cardiovascular Medicine|August 15, 2022
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivorsLukas J Motloch, Peter Jirak, Moritz Mirna, et al.Plos One|October 14, 2021
J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?Naufal Shamilevich Zagidullin, Lukas J Motloch, Timur Ilgamovich Musin, et al.Pageof 7